Clinical Trial Update: A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011) [Phase 1]

View source ↗

Summary

Phase 1 study of MK-2060 in participants with chronic kidney disease and end-stage renal disease completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Kidney Failure

Drugs mentioned

• MK-2060

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: End-Stage Renal Disease, End-Stage Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-09-10